Invention Grant
- Patent Title: Compounds αv β6 integrin antagonists
-
Application No.: US15514399Application Date: 2015-09-22
-
Publication No.: US09956209B2Publication Date: 2018-05-01
- Inventor: Niall Andrew Anderson , Matthew Howard James Campbell-Crawford , Ashley Paul Hancock , John Martin Pritchard , Joanna Mary Redmond
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Current Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Jane F. Djung; Kathryn A. Lutomski
- Priority: GB1417002.1 20140926
- International Application: PCT/EP2015/071776 WO 20150922
- International Announcement: WO2016/046225 WO 20160331
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; C07D471/04 ; A61K31/19
Abstract:
A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.
Public/Granted literature
- US20170290817A1 NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS Public/Granted day:2017-10-12
Information query
IPC分类:
